cbdMD (YCBD) Capital Expenditures (2016 - 2025)

cbdMD has disclosed Capital Expenditures across 10 years of filings, most recently posting $164802.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $164802.0, changed 0.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $184587.0 (up 8.73% YoY), and the FY2025 annual result was $184172.0, down 3.08% from the prior year.
• Capital Expenditures came in at $164802.0 for Q4 2025 at cbdMD, up from $2804.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $231030.0 in Q4 2021 to a low of -$102390.0 in Q1 2023.
• The 5-year median for Capital Expenditures is $102389.0 (2023), against an average of $93365.1.
• Across the five-year window, Capital Expenditures soared 643.93% in 2022 and tumbled 171.72% in 2023, its largest moves.
• cbdMD's Capital Expenditures stood at $231030.0 in 2021, then slipped by 23.23% to $177370.0 in 2022, then rose by 4.1% to $184635.0 in 2023, then decreased by 10.97% to $164387.0 in 2024, then increased by 0.25% to $164802.0 in 2025.
• The last three Capital Expenditures figures came in at $164802.0 (Q4 2025), $2804.0 (Q3 2025), and $1475.0 (Q2 2025), per Business Quant data.